HB 1195 Missouri House · 2025 Regular Session

Modifies provisions relating to access to medical products

HB 1195 caps out-of-pocket costs for insured patients using insulin medications and epinephrine auto-injectors. It limits a 30-day supply of covered insulin to $35 and epinephrine auto-injectors to $100, regardless of the medication type or quantity. These cost limits adjust annually based on changes in the medical care component of the Consumer Price Index. The bill applies to health insurance policies issued after August 28, 2025, and requires a one-time reporting requirement on pricing practices, though its key provisions expire January 1, 2026.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Feb 2025

Committee Review

Floor Vote

Governor

Introduced Feb 5, 2025 Last action May 14, 2025

Maddy AI version diff · 1 comparison

What changed between versions

Introduced → House Committee Substitute · 6 edits

MODERATE

The bill was substantially rewritten to shift from adding new sections to Chapter 376 about prescription costs to repealing an existing pharmacy practice section (338.010) and replacing it with expanded definitions of pharmacy practice. The original focus on insulin and epinephrine pricing limits was largely removed, though some related language remains in the new definitions. This represents a significant policy shift from cost control measures to pharmacy practice regulation.

Scope change

The bill changed from adding two new sections to Chapter 376 (insurance regulations) to repealing and replacing a section in Chapter 338 (pharmacy practice regulations). The focus shifted from prescription drug pricing limits to defining what constitutes the practice of pharmacy.

REQUIREMENT

Removed provisions limiting insulin and epinephrine auto-injector costs to $35 and $100 respectively for thirty-day supplies.

Removed the annual adjustment mechanism that would increase cost-sharing limits based on the Consumer Price Index.

TIMELINE

Removed the requirement for a report on insulin and epinephrine pricing practices to be completed before November 1, 2025.

DEFINITION

Added new definitions expanding the practice of pharmacy to include vaccine administration (with specific exclusions), nicotine replacement therapy, HIV postexposure prophylaxis, and emergency insulin supplies.

SCOPE

Changed the bill structure from adding sections to Chapter 376 to repealing and replacing section 338.010 in Chapter 338.

TECHNICAL

Changed the bill classification from 'Introduced' to 'House Committee Substitute' and updated section numbers from 2629H.01I to 2629H.03C.

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

May 14, 2025

Committee

Referred: Rules - Legislative(H)

lower

May 6, 2025

Lower · Passed

HCS Reported Do Pass (H) - AYES: 13 NOES: 0 PRESENT: 0

lower

May 5, 2025

Lower · Passed

HCS Voted Do Pass (H)

lower

Feb 27, 2025

Committee

Referred: Health and Mental Health(H)

lower

Feb 5, 2025

Introduced

Introduced and Read First Time (H)

lower

1 primary · 0 co-sponsors